CEO AmirAli Talasaz was paid $8,661,227 in fiscal year 2025, ↓ down 25.4% from fiscal year 2024, the 13th percentile of its disclosed peer group (SEC filing 0001193125-26-187403 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$8,661,227 ↓ AmirAli Talasaz total, FY2025 | 13th CEO pay percentile vs peers | 44:1 CEO-to-median pay ratio | 90.84% Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
Ask our research desk — $99, 24h, every figure cited to its filing.
GH's next annual pay disclosure, estimated April 27, 2027.est. Filing ↗
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| AmirAli Talasaz | $1 | $0 | $8,647,709 | $0 | $0 | $0 | $13,517 | $8,661,227 |
| Co-Chief Executive Officer | ||||||||
| Helmy Eltoukhy | 1 | 0 | 8,647,709 | 0 | 0 | 0 | 13,422 | 8,661,132 |
| Chairman and Co-Chief Executive Officer | ||||||||
| Michael Bell | 566,154 | 0 | 1,873,317 | 907,059 | 399,000 | 0 | 10,875 | 3,756,405 |
| Chief Financial Officer | ||||||||
| Darya Chudova | 520,192 | 10,000 | 1,756,012 | 824,606 | 367,500 | 0 | 10,729 | 3,489,039 |
| Chief Technology Officer | ||||||||
| John Saia | 527,116 | 5,000 | 1,545,291 | 725,663 | 371,000 | 0 | 11,314 | 3,185,384 |
| Chief Legal Officer and Corporate Secretary | ||||||||
| Craig Eagle | 576,154 | 10,000 | 1,404,827 | 659,701 | 304,500 | 0 | 14,975 | 2,970,157 |
| Chief Medical Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| AmirAli Talasaz | $8,661,227 | $11,613,545 | $26,415 | ↓ −2,952,318 |
| Helmy Eltoukhy | 8,661,132 | 11,613,450 | 11,591 | ↓ −2,952,318 |
| Michael Bell | 3,756,405 | 3,606,871 | 4,123,993 | ↑ +149,534 |
| Darya Chudova | 3,489,039 | 3,475,523 | 4,755,541 | ↑ +13,516 |
| John Saia | 3,185,384 | 3,203,146 | — | ↓ −17,762 |
| Craig Eagle | 2,970,157 | — | 3,485,356 | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read Guardant Health's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper GH reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
How we handle your data → Privacy
The list of companies that name GH as a peer is temporarily unavailable — recheck shortly.
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2025 total |
|---|---|---|
| Alex M. Azar II | Independent Director | $725,332 |
| Ian Clark | Lead Independent Director | $470,242 |
| Manuel Hidalgo Medina | Independent Director | $425,286 |
| Meghan Joyce | Independent Director | $425,286 |
| Musa Tariq | Independent Director | $425,286 |
| Myrtle Potter | Independent Director | $425,286 |
| Roberto Mignone | Independent Director | $425,286 |
| Steve Krognes | Independent Director | $425,286 |
| Vijaya Gadde | Independent Director | $425,286 |
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Helmy Eltoukhy | Director | 2026-06-30 | A | 2,817 | $0 | $0 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-06-30 | A | 2,817 | 0 | 0 | Common | Form 4 ↗ |
| Michael Bell | Chief Financial Officer | 2026-07-01 | A | 2,084 | 0 | 0 | Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-07-01 | A | 1,994 | 0 | 0 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-07-01 | D | 23,997 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-07-01 | D | 9,715 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-07-01 | A | 9,715 | 0 | 0 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-07-01 | — | 23,009 | — | — | 6 insiders, 15 accrual rows | ||
| Michael Bell | Chief Financial Officer | 2026-07-01 | D | 3,324 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael Bell | Chief Financial Officer | 2026-07-01 | D | 2,084 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael Bell | Chief Financial Officer | 2026-07-01 | D | 3,914 | 171 | 668,394 | Common | Form 4 ↗ |
| Michael Bell | Chief Financial Officer | 2026-07-01 | A | 1,870 | 0 | 0 | Common | Form 4 ↗ |
| Michael Bell | Chief Financial Officer | 2026-07-01 | A | 3,324 | 0 | 0 | Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-07-01 | D | 3,324 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-07-01 | A | 1,700 | 0 | 0 | Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-07-01 | A | 3,324 | 0 | 0 | Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-07-01 | A | 1,667 | 0 | 0 | Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-07-01 | A | 1,339 | 0 | 0 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-07-01 | D | 2,526 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-07-01 | D | 3,141 | 171 | 536,389 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-07-01 | A | 1,293 | 0 | 0 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-07-01 | A | 2,526 | 0 | 0 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-07-01 | A | 1,667 | 0 | 0 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-07-01 | A | 1,928 | 0 | 0 | Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-07-01 | D | 3,066 | 171 | 523,581 | Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-07-01 | A | 1,361 | 0 | 0 | Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-07-01 | A | 1,084 | 0 | 0 | Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-07-01 | A | 1,607 | 0 | 0 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-07-01 | D | 2,659 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-07-01 | A | 2,659 | 0 | 0 | Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-07-01 | D | 2,925 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-07-01 | D | 3,707 | 171 | 633,044 | Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-07-01 | A | 1,667 | 0 | 0 | Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-07-01 | A | 974 | 0 | 0 | Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-07-01 | D | 4,318 | 171 | 737,385 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-07-01 | A | 1,361 | 0 | 0 | Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-07-01 | A | 2,925 | 0 | 0 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-07-01 | D | 9,715 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-07-01 | D | 17,086 | 171 | 2,917,776 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-07-01 | A | 9,715 | 0 | 0 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-07-01 | A | 23,997 | 0 | 0 | Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-07-01 | D | 23,997 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-07-01 | D | 17,086 | 171 | 2,917,776 | Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-07-01 | A | 23,997 | 0 | 0 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-07-01 | D | 2,099 | 171 | 358,446 | Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-07-01 | A | 1,497 | 0 | 0 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-07-15 | — | 250 | — | — | 1 insider, 1 accrual row | ||
| Musa Tariq | Director | 2026-07-15 | A | 250 | 0 | 0 | Common | Form 4 ↗ |
| Musa Tariq | Director | 2026-07-16 | D | 116 | 163 | 18,942 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-07-17 | — | 232 | — | — | 1 insider, 1 accrual row | ||
| Medina Manuel Hidalgo | Director | 2026-07-17 | A | 232 | 0 | 0 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-07-21 | — | 264 | — | — | 1 insider, 1 accrual row | ||
| Roberto Mignone | Director | 2026-07-21 | A | 264 | 0 | 0 | Common | Form 4 ↗ |
| Ian Clark | Director | 2026-08-04 | D | 5,092 | 159 | 808,626 | Common | Form 4 ↗ |
| Ian Clark | Director | 2026-08-04 | D | 9,088 | 159 | 1,444,825 | Common | Form 4 ↗ |
| Ian Clark | Director | 2026-08-04 | A | 6,833 | 51 | 345,545 | Common | Form 4 ↗ |
| Ian Clark | Director | 2026-08-04 | A | 2,255 | 91 | 205,453 | Common | Form 4 ↗ |
| Ian Clark | Director | 2026-08-04 | D | 6,833 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Ian Clark | Director | 2026-08-04 | D | 2,255 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-08-05 | — | 950 | — | — | 1 insider, 1 accrual row | ||
| Medina Manuel Hidalgo | Director | 2026-08-05 | D | 750 | 165 | 123,454 | Common | Form 4 ↗ |
| Medina Manuel Hidalgo | Director | 2026-08-05 | D | 950 | 164 | 155,748 | Common | Form 4 ↗ |
| Medina Manuel Hidalgo | Director | 2026-08-05 | A | 950 | 33 | 30,923 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-08-10 | D | 28,193 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-08-10 | D | 3,463 | 167 | 579,639 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-08-10 | A | 28,193 | 28 | 799,835 | Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-08-10 | D | 800 | 0 | 0 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-08-10 | A | 75,000 | 0 | 0 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-08-10 | A | 35,412 | 110 | 3,912,672 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-08-10 | D | 35,412 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-08-10 | D | 17,413 | 170 | 2,964,401 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-08-10 | D | 75,000 | 0 | 0 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-08-10 | D | 35,364 | 170 | 5,998,926 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-08-10 | D | 7,365 | 169 | 1,243,145 | Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-08-11 | A | 35,000 | 0 | 0 | Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-08-11 | D | 35,000 | 0 | 0 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-08-12 | D | 14,012 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-08-12 | D | 13,248 | 166 | 2,200,584 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-08-12 | D | 19,014 | 165 | 3,140,310 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-08-12 | D | 9,934 | 164 | 1,631,870 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-08-12 | D | 3,704 | 163 | 605,286 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-08-12 | A | 14,012 | 29 | 400,883 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-08-12 | A | 32,288 | 20 | 650,280 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-08-12 | D | 32,288 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-08-12 | D | 400 | 168 | 67,168 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-08-15 | — | 250 | — | — | 1 insider, 1 accrual row | ||
| Musa Tariq | Director | 2026-08-15 | A | 250 | 0 | 0 | Common | Form 4 ↗ |
| Musa Tariq | Director | 2026-08-17 | D | 116 | 156 | 18,148 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-08-17 | — | 232 | — | — | 1 insider, 1 accrual row | ||
| Medina Manuel Hidalgo | Director | 2026-08-17 | A | 232 | 0 | 0 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-08-21 | — | 264 | — | — | 1 insider, 1 accrual row | ||
| Roberto Mignone | Director | 2026-08-21 | A | 264 | 0 | 0 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-08-21 | D | 7,589 | 170 | 1,292,302 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-08-21 | D | 20,888 | 169 | 3,533,452 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-08-21 | D | 9,023 | 168 | 1,517,631 | Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-08-26 | A | 25,000 | 0 | 0 | Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-08-26 | D | 25,000 | 0 | 0 | Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-08-26 | D | 30,000 | 0 | 0 | Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-09-11 | D | 4,000 | 158 | 632,193 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-09-12 | — | 1,651 | — | — | 1 insider, 1 accrual row | ||
| Alex M. Azar II | Director | 2026-09-12 | A | 1,651 | 0 | 0 | Common | Form 4 ↗ |
| Musa Tariq | Director | 2026-09-15 | A | 249 | 0 | 0 | Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-09-15 | D | 7,738 | 178 | 1,377,364 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-09-15 | — | 249 | — | — | 1 insider, 1 accrual row | ||
| Steve Krognes | Director | 2026-09-16 | D | 971 | 177 | 172,330 | Common | Form 4 ↗ |
| Steve Krognes | Director | 2026-09-16 | D | 1,300 | 176 | 229,236 | Common | Form 4 ↗ |
| Alex M. Azar II | Director | 2026-09-16 | D | 826 | 175 | 144,550 | Common | Form 4 ↗ |
| Musa Tariq | Director | 2026-09-16 | D | 116 | 175 | 20,300 | Common | Form 4 ↗ |
| Steve Krognes | Director | 2026-09-16 | D | 3,300 | 175 | 578,888 | Common | Form 4 ↗ |
| Steve Krognes | Director | 2026-09-16 | D | 1,103 | 174 | 192,432 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-09-17 | — | 232 | — | — | 1 insider, 1 accrual row | ||
| Medina Manuel Hidalgo | Director | 2026-09-17 | A | 232 | 0 | 0 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-09-21 | — | 264 | — | — | 1 insider, 1 accrual row | ||
| Roberto Mignone | Director | 2026-09-21 | A | 264 | 0 | 0 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-09-30 | D | 2,817 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-09-30 | D | 1,428 | 178 | 254,698 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-09-30 | A | 2,817 | 0 | 0 | Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-09-30 | D | 2,817 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-09-30 | D | 1,428 | 178 | 254,698 | Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-09-30 | A | 2,817 | 0 | 0 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-10-01 | — | 23,013 | — | — | 6 insiders, 15 accrual rows | ||
| Darya Chudova | Chief Technology Officer | 2026-10-01 | D | 3,324 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-10-01 | D | 4,320 | 175 | 754,920 | Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-10-01 | A | 1,701 | 0 | 0 | Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-10-01 | A | 3,324 | 0 | 0 | Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-10-01 | A | 1,668 | 0 | 0 | Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-10-01 | D | 2,925 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-10-01 | D | 3,706 | 175 | 647,624 | Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-10-01 | A | 1,340 | 0 | 0 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-10-01 | D | 9,716 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-10-01 | D | 23,997 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-10-01 | D | 17,087 | 175 | 2,985,953 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-10-01 | A | 9,716 | 0 | 0 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-10-01 | A | 23,997 | 0 | 0 | Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-10-01 | D | 9,716 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-10-01 | D | 23,997 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-10-01 | D | 17,087 | 175 | 2,985,953 | Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-10-01 | A | 9,716 | 0 | 0 | Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-10-01 | A | 23,997 | 0 | 0 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-10-01 | D | 2,659 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-10-01 | D | 2,098 | 175 | 366,626 | Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-10-01 | A | 1,496 | 0 | 0 | Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-10-01 | A | 2,925 | 0 | 0 | Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-10-01 | A | 1,668 | 0 | 0 | Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-10-01 | A | 974 | 0 | 0 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-10-01 | A | 1,360 | 0 | 0 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-10-01 | A | 2,659 | 0 | 0 | Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-10-01 | D | 3,067 | 175 | 535,958 | Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-10-01 | A | 1,360 | 0 | 0 | Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-10-01 | A | 1,995 | 0 | 0 | Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-10-01 | A | 1,084 | 0 | 0 | Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-10-01 | A | 1,607 | 0 | 0 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-10-01 | D | 2,527 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-10-01 | D | 3,143 | 175 | 549,239 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-10-01 | A | 1,292 | 0 | 0 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-10-01 | A | 2,527 | 0 | 0 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-10-01 | A | 1,668 | 0 | 0 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-10-01 | A | 1,929 | 0 | 0 | Common | Form 4 ↗ |
| Michael Bell | Chief Financial Officer | 2026-10-01 | D | 3,324 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael Bell | Chief Financial Officer | 2026-10-01 | D | 2,085 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael Bell | Chief Financial Officer | 2026-10-01 | D | 3,914 | 175 | 683,972 | Common | Form 4 ↗ |
| Michael Bell | Chief Financial Officer | 2026-10-01 | A | 1,871 | 0 | 0 | Common | Form 4 ↗ |
| Michael Bell | Chief Financial Officer | 2026-10-01 | A | 3,324 | 0 | 0 | Common | Form 4 ↗ |
| Michael Bell | Chief Financial Officer | 2026-10-01 | A | 2,085 | 0 | 0 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-10-12 | — | 137 | — | — | 1 insider, 1 accrual row | ||
| Alex M. Azar II | Director | 2026-10-12 | A | 137 | 0 | 0 | Common | Form 4 ↗ |
| Alex M. Azar II | Director | 2026-10-14 | D | 69 | 160 | 11,032 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-10-15 | — | 250 | — | — | 1 insider, 1 accrual row | ||
| Musa Tariq | Director | 2026-10-15 | A | 250 | 0 | 0 | Common | Form 4 ↗ |
| Musa Tariq | Director | 2026-10-16 | D | 116 | 166 | 19,242 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-10-17 | — | 232 | — | — | 1 insider, 1 accrual row | ||
| Medina Manuel Hidalgo | Director | 2026-10-17 | A | 232 | 0 | 0 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Helmy Eltoukhy | Director | 2026-06-30 | A | 2,817 | $0 | $0 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-06-30 | A | 2,817 | 0 | 0 | Common | Form 4 ↗ |
| Michael Bell | Chief Financial Officer | 2026-07-01 | A | 2,084 | 0 | 0 | Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-07-01 | A | 1,994 | 0 | 0 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-07-01 | D | 23,997 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-07-01 | D | 9,715 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-07-01 | A | 9,715 | 0 | 0 | Common | Form 4 ↗ |
| Michael Bell | Chief Financial Officer | 2026-07-01 | D | 1,870 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael Bell | Chief Financial Officer | 2026-07-01 | D | 3,324 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael Bell | Chief Financial Officer | 2026-07-01 | D | 2,084 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael Bell | Chief Financial Officer | 2026-07-01 | D | 3,914 | 171 | 668,394 | Common | Form 4 ↗ |
| Michael Bell | Chief Financial Officer | 2026-07-01 | A | 1,870 | 0 | 0 | Common | Form 4 ↗ |
| Michael Bell | Chief Financial Officer | 2026-07-01 | A | 3,324 | 0 | 0 | Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-07-01 | D | 1,700 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-07-01 | D | 3,324 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-07-01 | D | 1,667 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-07-01 | D | 1,339 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-07-01 | A | 1,700 | 0 | 0 | Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-07-01 | A | 3,324 | 0 | 0 | Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-07-01 | A | 1,667 | 0 | 0 | Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-07-01 | A | 1,339 | 0 | 0 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-07-01 | D | 1,293 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-07-01 | D | 2,526 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-07-01 | D | 1,667 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-07-01 | D | 1,928 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-07-01 | D | 3,141 | 171 | 536,389 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-07-01 | A | 1,293 | 0 | 0 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-07-01 | A | 2,526 | 0 | 0 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-07-01 | A | 1,667 | 0 | 0 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-07-01 | A | 1,928 | 0 | 0 | Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-07-01 | D | 1,361 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-07-01 | D | 1,994 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-07-01 | D | 1,084 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-07-01 | D | 1,607 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-07-01 | D | 3,066 | 171 | 523,581 | Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-07-01 | A | 1,361 | 0 | 0 | Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-07-01 | A | 1,084 | 0 | 0 | Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-07-01 | A | 1,607 | 0 | 0 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-07-01 | D | 1,361 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-07-01 | D | 2,659 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-07-01 | A | 2,659 | 0 | 0 | Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-07-01 | D | 2,925 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-07-01 | D | 1,667 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-07-01 | D | 974 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-07-01 | D | 3,707 | 171 | 633,044 | Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-07-01 | A | 1,667 | 0 | 0 | Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-07-01 | A | 974 | 0 | 0 | Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-07-01 | D | 4,318 | 171 | 737,385 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-07-01 | A | 1,361 | 0 | 0 | Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-07-01 | D | 1,497 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-07-01 | A | 2,925 | 0 | 0 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-07-01 | D | 9,715 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-07-01 | D | 17,086 | 171 | 2,917,776 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-07-01 | A | 9,715 | 0 | 0 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-07-01 | A | 23,997 | 0 | 0 | Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-07-01 | D | 23,997 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-07-01 | D | 17,086 | 171 | 2,917,776 | Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-07-01 | A | 23,997 | 0 | 0 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-07-01 | D | 2,099 | 171 | 358,446 | Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-07-01 | A | 1,497 | 0 | 0 | Common | Form 4 ↗ |
| Musa Tariq | Director | 2026-07-15 | D | 250 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Musa Tariq | Director | 2026-07-15 | A | 250 | 0 | 0 | Common | Form 4 ↗ |
| Musa Tariq | Director | 2026-07-16 | D | 116 | 163 | 18,942 | Common | Form 4 ↗ |
| Medina Manuel Hidalgo | Director | 2026-07-17 | D | 232 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Medina Manuel Hidalgo | Director | 2026-07-17 | A | 232 | 0 | 0 | Common | Form 4 ↗ |
| Roberto Mignone | Director | 2026-07-21 | D | 264 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Roberto Mignone | Director | 2026-07-21 | A | 264 | 0 | 0 | Common | Form 4 ↗ |
| Ian Clark | Director | 2026-08-04 | D | 5,092 | 159 | 808,626 | Common | Form 4 ↗ |
| Ian Clark | Director | 2026-08-04 | D | 9,088 | 159 | 1,444,825 | Common | Form 4 ↗ |
| Ian Clark | Director | 2026-08-04 | A | 6,833 | 51 | 345,545 | Common | Form 4 ↗ |
| Ian Clark | Director | 2026-08-04 | A | 2,255 | 91 | 205,453 | Common | Form 4 ↗ |
| Ian Clark | Director | 2026-08-04 | D | 6,833 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Ian Clark | Director | 2026-08-04 | D | 2,255 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Medina Manuel Hidalgo | Director | 2026-08-05 | D | 950 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Medina Manuel Hidalgo | Director | 2026-08-05 | D | 750 | 165 | 123,454 | Common | Form 4 ↗ |
| Medina Manuel Hidalgo | Director | 2026-08-05 | D | 950 | 164 | 155,748 | Common | Form 4 ↗ |
| Medina Manuel Hidalgo | Director | 2026-08-05 | A | 950 | 33 | 30,923 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-08-10 | D | 28,193 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-08-10 | D | 3,463 | 167 | 579,639 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-08-10 | A | 28,193 | 28 | 799,835 | Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-08-10 | D | 800 | 0 | 0 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-08-10 | A | 75,000 | 0 | 0 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-08-10 | A | 35,412 | 110 | 3,912,672 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-08-10 | D | 35,412 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-08-10 | D | 17,413 | 170 | 2,964,401 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-08-10 | D | 75,000 | 0 | 0 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-08-10 | D | 35,364 | 170 | 5,998,926 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-08-10 | D | 7,365 | 169 | 1,243,145 | Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-08-11 | A | 35,000 | 0 | 0 | Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-08-11 | D | 35,000 | 0 | 0 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-08-12 | D | 14,012 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-08-12 | D | 13,248 | 166 | 2,200,584 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-08-12 | D | 19,014 | 165 | 3,140,310 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-08-12 | D | 9,934 | 164 | 1,631,870 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-08-12 | D | 3,704 | 163 | 605,286 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-08-12 | A | 14,012 | 29 | 400,883 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-08-12 | A | 32,288 | 20 | 650,280 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-08-12 | D | 32,288 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-08-12 | D | 400 | 168 | 67,168 | Common | Form 4 ↗ |
| Musa Tariq | Director | 2026-08-15 | D | 250 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Musa Tariq | Director | 2026-08-15 | A | 250 | 0 | 0 | Common | Form 4 ↗ |
| Musa Tariq | Director | 2026-08-17 | D | 116 | 156 | 18,148 | Common | Form 4 ↗ |
| Medina Manuel Hidalgo | Director | 2026-08-17 | D | 232 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Medina Manuel Hidalgo | Director | 2026-08-17 | A | 232 | 0 | 0 | Common | Form 4 ↗ |
| Roberto Mignone | Director | 2026-08-21 | D | 264 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Roberto Mignone | Director | 2026-08-21 | A | 264 | 0 | 0 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-08-21 | D | 7,589 | 170 | 1,292,302 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-08-21 | D | 20,888 | 169 | 3,533,452 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-08-21 | D | 9,023 | 168 | 1,517,631 | Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-08-26 | A | 25,000 | 0 | 0 | Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-08-26 | D | 25,000 | 0 | 0 | Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-08-26 | D | 30,000 | 0 | 0 | Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-09-11 | D | 4,000 | 158 | 632,193 | Common | Form 4 ↗ |
| Alex M. Azar II | Director | 2026-09-12 | D | 1,651 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Alex M. Azar II | Director | 2026-09-12 | A | 1,651 | 0 | 0 | Common | Form 4 ↗ |
| Musa Tariq | Director | 2026-09-15 | A | 249 | 0 | 0 | Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-09-15 | D | 7,738 | 178 | 1,377,364 | Common | Form 4 ↗ |
| Musa Tariq | Director | 2026-09-15 | D | 249 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Steve Krognes | Director | 2026-09-16 | D | 971 | 177 | 172,330 | Common | Form 4 ↗ |
| Steve Krognes | Director | 2026-09-16 | D | 1,300 | 176 | 229,236 | Common | Form 4 ↗ |
| Alex M. Azar II | Director | 2026-09-16 | D | 826 | 175 | 144,550 | Common | Form 4 ↗ |
| Musa Tariq | Director | 2026-09-16 | D | 116 | 175 | 20,300 | Common | Form 4 ↗ |
| Steve Krognes | Director | 2026-09-16 | D | 3,300 | 175 | 578,888 | Common | Form 4 ↗ |
| Steve Krognes | Director | 2026-09-16 | D | 1,103 | 174 | 192,432 | Common | Form 4 ↗ |
| Medina Manuel Hidalgo | Director | 2026-09-17 | D | 232 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Medina Manuel Hidalgo | Director | 2026-09-17 | A | 232 | 0 | 0 | Common | Form 4 ↗ |
| Roberto Mignone | Director | 2026-09-21 | D | 264 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Roberto Mignone | Director | 2026-09-21 | A | 264 | 0 | 0 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-09-30 | D | 2,817 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-09-30 | D | 1,428 | 178 | 254,698 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-09-30 | A | 2,817 | 0 | 0 | Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-09-30 | D | 2,817 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-09-30 | D | 1,428 | 178 | 254,698 | Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-09-30 | A | 2,817 | 0 | 0 | Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-10-01 | D | 1,701 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-10-01 | D | 3,324 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-10-01 | D | 1,668 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-10-01 | D | 1,340 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-10-01 | D | 4,320 | 175 | 754,920 | Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-10-01 | A | 1,701 | 0 | 0 | Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-10-01 | A | 3,324 | 0 | 0 | Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-10-01 | A | 1,668 | 0 | 0 | Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-10-01 | D | 2,925 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-10-01 | D | 3,706 | 175 | 647,624 | Common | Form 4 ↗ |
| Darya Chudova | Chief Technology Officer | 2026-10-01 | A | 1,340 | 0 | 0 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-10-01 | D | 9,716 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-10-01 | D | 23,997 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-10-01 | D | 17,087 | 175 | 2,985,953 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-10-01 | A | 9,716 | 0 | 0 | Common | Form 4 ↗ |
| AmirAli Talasaz | Director | 2026-10-01 | A | 23,997 | 0 | 0 | Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-10-01 | D | 9,716 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-10-01 | D | 23,997 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-10-01 | D | 17,087 | 175 | 2,985,953 | Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-10-01 | A | 9,716 | 0 | 0 | Common | Form 4 ↗ |
| Helmy Eltoukhy | Director | 2026-10-01 | A | 23,997 | 0 | 0 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-10-01 | D | 1,360 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-10-01 | D | 2,659 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-10-01 | D | 2,098 | 175 | 366,626 | Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-10-01 | A | 1,496 | 0 | 0 | Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-10-01 | A | 2,925 | 0 | 0 | Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-10-01 | A | 1,668 | 0 | 0 | Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-10-01 | A | 974 | 0 | 0 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-10-01 | A | 1,360 | 0 | 0 | Common | Form 4 ↗ |
| Terilyn J. Monroe | Chief People Officer | 2026-10-01 | A | 2,659 | 0 | 0 | Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-10-01 | D | 1,360 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-10-01 | D | 1,995 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-10-01 | D | 1,084 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-10-01 | D | 1,607 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-10-01 | D | 3,067 | 175 | 535,958 | Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-10-01 | A | 1,360 | 0 | 0 | Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-10-01 | A | 1,995 | 0 | 0 | Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-10-01 | A | 1,084 | 0 | 0 | Common | Form 4 ↗ |
| Kumud Kalia | Chief Information Officer | 2026-10-01 | A | 1,607 | 0 | 0 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-10-01 | D | 1,292 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-10-01 | D | 2,527 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-10-01 | D | 1,668 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-10-01 | D | 1,929 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-10-01 | D | 3,143 | 175 | 549,239 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-10-01 | A | 1,292 | 0 | 0 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-10-01 | A | 2,527 | 0 | 0 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-10-01 | A | 1,668 | 0 | 0 | Common | Form 4 ↗ |
| Chris Freeman | Chief Commercial Officer | 2026-10-01 | A | 1,929 | 0 | 0 | Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-10-01 | D | 1,496 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-10-01 | D | 1,668 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John Saia | Chief Legal Officer | 2026-10-01 | D | 974 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael Bell | Chief Financial Officer | 2026-10-01 | D | 1,871 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael Bell | Chief Financial Officer | 2026-10-01 | D | 3,324 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael Bell | Chief Financial Officer | 2026-10-01 | D | 2,085 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael Bell | Chief Financial Officer | 2026-10-01 | D | 3,914 | 175 | 683,972 | Common | Form 4 ↗ |
| Michael Bell | Chief Financial Officer | 2026-10-01 | A | 1,871 | 0 | 0 | Common | Form 4 ↗ |
| Michael Bell | Chief Financial Officer | 2026-10-01 | A | 3,324 | 0 | 0 | Common | Form 4 ↗ |
| Michael Bell | Chief Financial Officer | 2026-10-01 | A | 2,085 | 0 | 0 | Common | Form 4 ↗ |
| Alex M. Azar II | Director | 2026-10-12 | D | 137 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Alex M. Azar II | Director | 2026-10-12 | A | 137 | 0 | 0 | Common | Form 4 ↗ |
| Alex M. Azar II | Director | 2026-10-14 | D | 69 | 160 | 11,032 | Common | Form 4 ↗ |
| Musa Tariq | Director | 2026-10-15 | D | 250 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Musa Tariq | Director | 2026-10-15 | A | 250 | 0 | 0 | Common | Form 4 ↗ |
| Musa Tariq | Director | 2026-10-16 | D | 116 | 166 | 19,242 | Common | Form 4 ↗ |
| Medina Manuel Hidalgo | Director | 2026-10-17 | D | 232 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Medina Manuel Hidalgo | Director | 2026-10-17 | A | 232 | 0 | 0 | Common | Form 4 ↗ |
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Helmy Eltoukhy | RSU | 2025-03-12 | — | — | 19,258 | — | $830,020 |
| John Saia | RSU | 2025-03-12 | — | — | 17,866 | — | 770,025 |
| Darya Chudova | RSU | 2025-03-12 | — | — | 20,302 | — | 875,016 |
| Michael Bell | RSU | 2025-03-12 | — | — | 22,332 | — | 962,509 |
| Helmy Eltoukhy | PSU | 2025-03-12 | 14,501 | 38,670 | — | 96,675 | 1,987,638 |
| Helmy Eltoukhy | RSU | 2025-03-12 | — | — | 116,010 | — | 5,000,031 |
| John Saia | PSU | 2025-03-12 | 5,656 | 15,083 | — | 37,708 | 775,266 |
| John Saia | OPTION | 2025-03-12 | — | — | 26,799 | — | 725,663 |
| Craig Eagle | OPTION | 2025-03-12 | — | — | 24,363 | — | 659,701 |
| Darya Chudova | OPTION | 2025-03-12 | — | — | 30,453 | — | 824,606 |
| Craig Eagle | PSU | 2025-03-12 | 5,142 | 13,712 | — | 34,280 | 704,797 |
| AmirAli Talasaz | PSU | 2025-03-12 | 481 | 19,258 | — | 38,516 | 830,020 |
| Darya Chudova | PSU | 2025-03-12 | 6,428 | 17,140 | — | 42,850 | 880,996 |
| Helmy Eltoukhy | PSU | 2025-03-12 | 481 | 19,258 | — | 38,516 | 830,020 |
| AmirAli Talasaz | RSU | 2025-03-12 | — | — | 19,258 | — | 830,020 |
| Craig Eagle | RSU | 2025-03-12 | — | — | 16,242 | — | 700,030 |
| AmirAli Talasaz | PSU | 2025-03-12 | 14,501 | 38,670 | — | 96,675 | 1,987,638 |
| AmirAli Talasaz | RSU | 2025-03-12 | — | — | 116,010 | — | 5,000,031 |
| Michael Bell | PSU | 2025-03-12 | 6,645 | 17,720 | — | 44,300 | 910,808 |
| Michael Bell | OPTION | 2025-03-12 | — | — | 33,498 | — | 907,059 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Helmy Eltoukhy | $5,830,051 | $2,817,658 | $0 | 32.6% |
| John Saia | 770,025 | 775,266 | 725,663 | 34.1% |
| Darya Chudova | 875,016 | 880,996 | 824,606 | 34.1% |
| Michael Bell | 962,509 | 910,808 | 907,059 | 32.8% |
| Craig Eagle | 700,030 | 704,797 | 659,701 | 34.1% |
| AmirAli Talasaz | 5,830,051 | 2,817,658 | 0 | 32.6% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Darya Chudova | RSU | 262,500 | — | $25,121,250 |
| Michael Bell | RSU | 285,000 | — | 27,274,500 |
| Helmy Eltoukhy | RSU | 830,000 | — | 79,431,000 |
| John Saia | RSU | 265,000 | — | 25,360,500 |
| AmirAli Talasaz | RSU | 830,000 | — | 79,431,000 |
The Compensation Committee believes that a well-designed compensation program should (i) align executive interests with the drivers of growth and stockholder returns, (ii) incent and reward the Company's achievement of its strategic business goals, and (iii) support the Company's ability to attract top talent and retain critical employees with the mindset, skills and capabilities to drive and sustain long-term stockholder value.
| CEO STI target (% of salary) | 100% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Aon |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | True |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-17 | 98,236,639 | 9,905,190 | 301,610 | 90.84% | Passed |
| 2025 | 2025-06-18 | 91,189,702 | 7,020,245 | 364,534 | 92.85% | Passed |
| 2024 | 2024-06-12 | 84,585,946 | 5,812,828 | 604,766 | 93.57% | Passed |
| 2023 | 2023-06-14 | 66,909,185 | 10,481,515 | 178,806 | 86.46% | Passed |
| 2022 | 2022-06-15 | 50,606,023 | 32,094,830 | 427,610 | 61.19% | Passed |
| 2021 | 2021-06-16 | 31,453,282 | 51,134,931 | 74,071 | 38.08% | Failed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-06-17 | 90.84%a |
| 2025 | 2025-06-18 | 92.85%b |
| 2024 | 2024-06-12 | 93.57%c |
a. Approved under the standard stated in the filing — “Abstentions are considered to be votes not cast on this proposal and thus will have no effect.”.
b. Approved under the standard stated in the filing — “Abstentions are considered to be votes not cast on this proposal and thus will have no effect.”.
c. Approved under the standard stated in the filing — “Abstentions are considered to be votes not cast on this proposal and thus will have no effect.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 44 : 1 |
|---|---|
| CEO total compensation | $8,661,227 |
| Median employee compensation | $198,418 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Alex M. Azar IIIndependent · Nominating and Corporate Governance · Newly elected | $0 | $362,527 | $362,805 | $0 | $0 | $725,332 |
| Ian ClarkIndependent · Lead Independent Director · Nominating and Corporate Governance (Chair) · Governance (Chair) | 0 | 257,502 | 212,740 | 0 | 0 | 470,242 |
| Meghan JoyceIndependent · Audit · Compensation · Not standing for re-election | 0 | 212,546 | 212,740 | 0 | 0 | 425,286 |
| Myrtle PotterIndependent · Audit · Compensation | 0 | 212,546 | 212,740 | 0 | 0 | 425,286 |
| Musa TariqIndependent · Nominating and Corporate Governance | 0 | 212,546 | 212,740 | 0 | 0 | 425,286 |
| Vijaya GaddeIndependent · Compensation (Chair) | 0 | 212,546 | 212,740 | 0 | 0 | 425,286 |
| Manuel Hidalgo MedinaIndependent · Nominating and Corporate Governance | 0 | 212,546 | 212,740 | 0 | 0 | 425,286 |
| Steve KrognesIndependent · Audit (Chair) | 0 | 212,546 | 212,740 | 0 | 0 | 425,286 |
| Roberto MignoneIndependent · Audit | 0 | 212,546 | 212,740 | 0 | 0 | 425,286 |
| AmirAli TalasazEmployee director | 0 | 0 | 0 | — | 0 | 0 |
| Helmy EltoukhyEmployee director · Board Chair | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | $60,000 |
|---|---|
| Annual equity retainer | $350,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 20,000 / 15,000 |
| Stock ownership guideline | $250,000 |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $0 |
| Equity awards (grant-date value) | $2,107,851 |
| All other compensation | $0 |
| Total cost of the board | $2,107,851 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies Guardant Health names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Guardant Health.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Tempus AI, Inc. | 2025 | Eric Lefkofsky | $783,333 | $39,992,500 | $0 | $720,000 | $41,495,833 |
| 2 | Exelixis, Inc. | 2025 | Michael Morrissey | 1,306,040 | 30,539,552 | 0 | 1,382,591 | 33,239,183 |
| 3 | BioMarin Pharmaceuticals Inc. | 2025 | Alexander Hardy | 1,130,769 | 16,833,629 | 1,909,310 | 1,644,500 | 21,927,563 |
| 4 | Masimo Corporation | 2025 | Catherine Szyman | 850,048 | 16,388,693 | 1,399,998 | 1,130,000 | 19,797,140 |
| 5 | Insulet Corporation | 2025 | Ashley McEvoy | 729,808 | 12,958,850 | 2,999,913 | 2,031,562 | 18,858,968 |
| 6 | United Therapeutics Corp | 2025 | Martine Rothblatt | 1,545,005 | 6,067,990 | 6,075,804 | 4,281,875 | 18,038,972 |
| 7 | Exact Sciences Corporation | 2024 | Kevin Conroy | 1,083,368 | 13,496,138 | 0 | 712,329 | 15,539,378 |
| 8 | Natera, Inc. | 2025 | Steven Chapman | 853,710 | 12,979,558 | 0 | 1,114,151 | 14,957,319 |
| 9 | Alnylam Pharmaceuticals, Inc. | 2025 | Yvonne Greenstreet | 1,404,200 | 5,512,500 | 4,363,380 | 3,562,500 | 14,867,600 |
| 10 | IDEXX Laboratories, Inc. | 2025 | Jonathan Mazelsky | 1,150,000 | 5,399,881 | 5,400,001 | 2,593,000 | 14,580,122 |
| 11 | Neurocrine Biosciences, Inc. | 2025 | Kyle Gano | 920,000 | 5,750,023 | 5,750,006 | 0 | 13,448,935 |
| 12 | Illumina, Inc. | 2025 | Jacob Thaysen | 1,000,000 | 8,763,122 | 0 | 1,155,000 | 11,018,895 |
| 13 | iRhythm Technologies, Inc. | 2025 | Quentin Blackford | 700,003 | 8,919,457 | 0 | 1,350,000 | 11,003,163 |
| 14 | NeoGenomics, Inc. | 2025 | Tony Zook | 601,539 | 3,999,997 | 3,998,235 | 513,400 | 9,127,092 |
| 15 | Guardant Health | 2025 | AmirAli Talasaz | 1 | 8,647,709 | 0 | 0 | 8,661,227 |
| 16 | ACADIA Pharmaceuticals Inc. | 2025 | Catherine Owen Adams | 930,000 | 3,240,558 | 3,234,797 | 818,559 | 8,256,518 |
| 17 | Dexcom, Inc. | 2025 | Jacob Leach | 768,962 | 5,936,062 | 0 | 1,164,780 | 7,985,960 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Guardant Health | 140% | PSU 50 · RSU 50 | No | Aon |
| ACADIA Pharmaceuticals Inc. | 110% | Options 50 · PSU 25 · RSU 25 | Yes | Frederic W. Cook & Co., Inc. (FW Cook) |
| Alnylam Pharmaceuticals, Inc. | 200% | PSU 50 · RSU 25 · Option 25 | No | Pay Governance |
| BioMarin Pharmaceuticals Inc. | 130% | PSU 66 · RSU 21 · Options 13 | Yes — Relative TSR | Aon Human Capital Solutions |
| Dexcom, Inc. | not disclosed | not disclosed | Yes — Relative TSR Performance Metric | Aon Hewitt Consulting Company |
| Exact Sciences Corporation | 47% | PSU 60 · RSU 40 | No | Aon |
| Exelixis, Inc. | 105% | PSU 50 · RSU 50 | Yes — 2025 Relative TSR Goal | Aon |
| IDEXX Laboratories, Inc. | 140% | Options 50 · PSU 50 | No | Farient |
| Illumina, Inc. | 1155% | not disclosed | Yes — 3-year rTSR performance against select companies in the Nasdaq Biotechnology Index | Aon (Aon's Human Capital Practice, a division of Aon, plc) |
| Insulet Corporation | 195.8% | PSU 60 · RSU 20 · Options 20 | No | Pearl Meyer & Partners, LLC |
| iRhythm Technologies, Inc. | 173% | RSU 50 · PSU 50 | Yes — Relative TSR | Aon and Mercer |
| Masimo Corporation | not disclosed | not disclosed | not disclosed | FW Cook |
| Natera, Inc. | 131.1% | PSU 50 · RSU 50 | No | Aon |
| NeoGenomics, Inc. | 60% | RSU 50 · Options 50 | not disclosed | WTW |
| Neurocrine Biosciences, Inc. | 105% | Options 50 · PSU 30 · RSU 20 | No | Frederic W. Cook & Co., Inc. |
| Tempus AI, Inc. | 90% | PSU 100 | Yes — TSR of at least 300 basis points higher than the return of the Nasdaq Composite Index | Compensia, Inc. |
| United Therapeutics Corp | 221% | PSO 50 · PSU 50 | No | Aon |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, AmirAli Talasaz | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “2025 Summary Compensation Table”. As printed: 8,661,227. Filing ↗machine: r7 · c31 · span 773149–773158 |
| 2 | Section 01, Helmy Eltoukhy | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “2025 Summary Compensation Table”. As printed: 8,661,132. Filing ↗machine: r4 · c31 · span 765505–765514 |
| 3 | Section 01, Michael Bell | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “2025 Summary Compensation Table”. As printed: 3,756,405. Filing ↗machine: r11 · c31 · span 781187–781196 |
| 4 | Section 01, Darya Chudova | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Summary Compensation Table”. As printed: 3,489,039. Filing ↗machine: r14 · c31 · span 788764–788773 |
| 5 | Section 01, John Saia | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Summary Compensation Table”. As printed: 3,185,384. Filing ↗machine: r20 · c31 · span 804972–804981 |
| 6 | Section 01, Craig Eagle | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “2025 Summary Compensation Table”. As printed: 2,970,157. Filing ↗machine: r17 · c31 · span 796885–796894 |
| 7 | Section 03, Helmy Eltoukhy RSU | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t172 · r5 · c47 · span 836322–836329 |
| 8 | Section 03, John Saia RSU | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t172 · r28 · c47 · span 908206–908213 |
| 9 | Section 03, Darya Chudova RSU | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t172 · r20 · c47 · span 883247–883254 |
| 10 | Section 03, Michael Bell RSU | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t172 · r16 · c47 · span 870675–870682 |
| 11 | Section 03, Helmy Eltoukhy PSU | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t172 · r6 · c47 · span 839436–839445 |
| 12 | Section 03, Helmy Eltoukhy RSU | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t172 · r8 · c47 · span 845671–845680 |
| 13 | Section 03, John Saia PSU | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t172 · r27 · c47 · span 905065–905072 |
| 14 | Section 03, John Saia OPTION | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t164 · r20 · c19 · span 804016–804023 |
| 15 | Section 03, Craig Eagle OPTION | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t164 · r17 · c19 · span 795929–795936 |
| 16 | Section 03, Darya Chudova OPTION | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t164 · r14 · c19 · span 787808–787815 |
| 17 | Section 03, Craig Eagle PSU | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t172 · r23 · c47 · span 892522–892529 |
| 18 | Section 03, AmirAli Talasaz PSU | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t172 · r10 · c47 · span 851996–852003 |
| 19 | Section 03, Darya Chudova PSU | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t172 · r19 · c47 · span 880106–880113 |
| 20 | Section 03, Helmy Eltoukhy PSU | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t172 · r5 · c47 · span 836322–836329 |
| 21 | Section 03, AmirAli Talasaz RSU | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t172 · r10 · c47 · span 851996–852003 |
| 22 | Section 03, Craig Eagle RSU | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t172 · r24 · c47 · span 895638–895645 |
| 23 | Section 03, AmirAli Talasaz PSU | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t172 · r11 · c47 · span 855135–855144 |
| 24 | Section 03, AmirAli Talasaz RSU | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t172 · r13 · c47 · span 861420–861429 |
| 25 | Section 03, Michael Bell PSU | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t172 · r15 · c47 · span 867559–867566 |
| 26 | Section 03, Michael Bell OPTION | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t164 · r11 · c19 · span 780411–780418 |
| 27 | Section 07, pay ratio | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “CEO Pay Ratio”. As printed: 44 : 1. Filing ↗machine: span 1262758–1262760 |
| 28 | Section 08, Alex M. Azar II | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Director Compensation”. As printed: 725,332. Filing ↗machine: t76 · r2 · c27 · span 355027–355121 |
| 29 | Section 08, Ian Clark | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Director Compensation”. As printed: 470,242. Filing ↗machine: t76 · r3 · c27 · span 358800–358894 |
| 30 | Section 08, Meghan Joyce | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Director Compensation”. As printed: 425,286. Filing ↗machine: t76 · r6 · c27 · span 370187–370281 |
| 31 | Section 08, Myrtle Potter | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Director Compensation”. As printed: 425,286. Filing ↗machine: t76 · r9 · c27 · span 381545–381639 |
| 32 | Section 08, Musa Tariq | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Director Compensation”. As printed: 425,286. Filing ↗machine: t76 · r10 · c27 · span 385344–385438 |
| 33 | Section 08, Vijaya Gadde | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Director Compensation”. As printed: 425,286. Filing ↗machine: t76 · r4 · c27 · span 362601–362695 |
| 34 | Section 08, Manuel Hidalgo Medina | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Director Compensation”. As printed: 425,286. Filing ↗machine: t76 · r5 · c27 · span 366386–366480 |
| 35 | Section 08, Steve Krognes | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Director Compensation”. As printed: 425,286. Filing ↗machine: t76 · r7 · c27 · span 373964–374058 |
| 36 | Section 08, Roberto Mignone | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Director Compensation”. As printed: 425,286. Filing ↗machine: t76 · r8 · c27 · span 377768–377862 |
| 37 | Section 08, AmirAli Talasaz | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 38 | Section 08, Helmy Eltoukhy | DEF 14A | 2026-04-28 | 0001193125-26-187403 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 39 | Section 02, Helmy Eltoukhy 2026-06-30 | Form 4 | 2026-07-02 | 0001752968-26-000012 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 40 | Section 02, AmirAli Talasaz 2026-06-30 | Form 4 | 2026-07-02 | 0001753159-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 41 | Section 02, Michael Bell 2026-07-01 | Form 4 | 2026-07-02 | 0001702824-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 42 | Section 02, Kumud Kalia 2026-07-01 | Form 4 | 2026-07-02 | 0001927831-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 43 | Section 02, AmirAli Talasaz 2026-07-01 | Form 4 | 2026-07-02 | 0001753159-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 44 | Section 02, Helmy Eltoukhy 2026-07-01 | Form 4 | 2026-07-02 | 0001752968-26-000012 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 45 | Section 02, Helmy Eltoukhy 2026-07-01 | Form 4 | 2026-07-02 | 0001752968-26-000012 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 46 | Section 02, Michael Bell 2026-07-01 | Form 4 | 2026-07-02 | 0001702824-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 47 | Section 02, Michael Bell 2026-07-01 | Form 4 | 2026-07-02 | 0001702824-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 48 | Section 02, Michael Bell 2026-07-01 | Form 4 | 2026-07-02 | 0001702824-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 49 | Section 02, Michael Bell 2026-07-01 | Form 4 | 2026-07-02 | 0001702824-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 50 | Section 02, Michael Bell 2026-07-01 | Form 4 | 2026-07-02 | 0001702824-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 51 | Section 02, Michael Bell 2026-07-01 | Form 4 | 2026-07-02 | 0001702824-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 52 | Section 02, Darya Chudova 2026-07-01 | Form 4 | 2026-07-02 | 0001977179-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 53 | Section 02, Darya Chudova 2026-07-01 | Form 4 | 2026-07-02 | 0001977179-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 54 | Section 02, Darya Chudova 2026-07-01 | Form 4 | 2026-07-02 | 0001977179-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 55 | Section 02, Darya Chudova 2026-07-01 | Form 4 | 2026-07-02 | 0001977179-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 56 | Section 02, Darya Chudova 2026-07-01 | Form 4 | 2026-07-02 | 0001977179-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 57 | Section 02, Darya Chudova 2026-07-01 | Form 4 | 2026-07-02 | 0001977179-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 58 | Section 02, Darya Chudova 2026-07-01 | Form 4 | 2026-07-02 | 0001977179-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 59 | Section 02, Darya Chudova 2026-07-01 | Form 4 | 2026-07-02 | 0001977179-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 60 | Section 02, Chris Freeman 2026-07-01 | Form 4 | 2026-07-02 | 0001871615-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 61 | Section 02, Chris Freeman 2026-07-01 | Form 4 | 2026-07-02 | 0001871615-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 62 | Section 02, Chris Freeman 2026-07-01 | Form 4 | 2026-07-02 | 0001871615-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 63 | Section 02, Chris Freeman 2026-07-01 | Form 4 | 2026-07-02 | 0001871615-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 64 | Section 02, Chris Freeman 2026-07-01 | Form 4 | 2026-07-02 | 0001871615-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 65 | Section 02, Chris Freeman 2026-07-01 | Form 4 | 2026-07-02 | 0001871615-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 66 | Section 02, Chris Freeman 2026-07-01 | Form 4 | 2026-07-02 | 0001871615-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 67 | Section 02, Chris Freeman 2026-07-01 | Form 4 | 2026-07-02 | 0001871615-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 68 | Section 02, Chris Freeman 2026-07-01 | Form 4 | 2026-07-02 | 0001871615-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 69 | Section 02, Kumud Kalia 2026-07-01 | Form 4 | 2026-07-02 | 0001927831-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 70 | Section 02, Kumud Kalia 2026-07-01 | Form 4 | 2026-07-02 | 0001927831-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 71 | Section 02, Kumud Kalia 2026-07-01 | Form 4 | 2026-07-02 | 0001927831-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 72 | Section 02, Kumud Kalia 2026-07-01 | Form 4 | 2026-07-02 | 0001927831-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 73 | Section 02, Kumud Kalia 2026-07-01 | Form 4 | 2026-07-02 | 0001927831-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 74 | Section 02, Kumud Kalia 2026-07-01 | Form 4 | 2026-07-02 | 0001927831-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 75 | Section 02, Kumud Kalia 2026-07-01 | Form 4 | 2026-07-02 | 0001927831-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 76 | Section 02, Kumud Kalia 2026-07-01 | Form 4 | 2026-07-02 | 0001927831-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 77 | Section 02, Terilyn J. Monroe 2026-07-01 | Form 4 | 2026-07-02 | 0001652956-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 78 | Section 02, Terilyn J. Monroe 2026-07-01 | Form 4 | 2026-07-02 | 0001652956-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 79 | Section 02, Terilyn J. Monroe 2026-07-01 | Form 4 | 2026-07-02 | 0001652956-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 80 | Section 02, John Saia 2026-07-01 | Form 4 | 2026-07-02 | 0001737840-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 81 | Section 02, John Saia 2026-07-01 | Form 4 | 2026-07-02 | 0001737840-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 82 | Section 02, John Saia 2026-07-01 | Form 4 | 2026-07-02 | 0001737840-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 83 | Section 02, John Saia 2026-07-01 | Form 4 | 2026-07-02 | 0001737840-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 84 | Section 02, John Saia 2026-07-01 | Form 4 | 2026-07-02 | 0001737840-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 85 | Section 02, John Saia 2026-07-01 | Form 4 | 2026-07-02 | 0001737840-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 86 | Section 02, Darya Chudova 2026-07-01 | Form 4 | 2026-07-02 | 0001977179-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 87 | Section 02, Terilyn J. Monroe 2026-07-01 | Form 4 | 2026-07-02 | 0001652956-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 88 | Section 02, John Saia 2026-07-01 | Form 4 | 2026-07-02 | 0001737840-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 89 | Section 02, John Saia 2026-07-01 | Form 4 | 2026-07-02 | 0001737840-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 90 | Section 02, AmirAli Talasaz 2026-07-01 | Form 4 | 2026-07-02 | 0001753159-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 91 | Section 02, AmirAli Talasaz 2026-07-01 | Form 4 | 2026-07-02 | 0001753159-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 92 | Section 02, AmirAli Talasaz 2026-07-01 | Form 4 | 2026-07-02 | 0001753159-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 93 | Section 02, AmirAli Talasaz 2026-07-01 | Form 4 | 2026-07-02 | 0001753159-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 94 | Section 02, Helmy Eltoukhy 2026-07-01 | Form 4 | 2026-07-02 | 0001752968-26-000012 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 95 | Section 02, Helmy Eltoukhy 2026-07-01 | Form 4 | 2026-07-02 | 0001752968-26-000012 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 96 | Section 02, Helmy Eltoukhy 2026-07-01 | Form 4 | 2026-07-02 | 0001752968-26-000012 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 97 | Section 02, Terilyn J. Monroe 2026-07-01 | Form 4 | 2026-07-02 | 0001652956-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 98 | Section 02, John Saia 2026-07-01 | Form 4 | 2026-07-02 | 0001737840-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 99 | Section 02, Musa Tariq 2026-07-15 | Form 4 | 2026-07-16 | 0001968281-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 100 | Section 02, Musa Tariq 2026-07-15 | Form 4 | 2026-07-16 | 0001968281-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 101 | Section 02, Musa Tariq 2026-07-16 | Form 4 | 2026-07-16 | 0001968281-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 102 | Section 02, Medina Manuel Hidalgo 2026-07-17 | Form 4 | 2026-07-20 | 0001865525-26-000022 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 103 | Section 02, Medina Manuel Hidalgo 2026-07-17 | Form 4 | 2026-07-20 | 0001865525-26-000022 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 104 | Section 02, Roberto Mignone 2026-07-21 | Form 4 | 2026-07-22 | 0001258394-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 105 | Section 02, Roberto Mignone 2026-07-21 | Form 4 | 2026-07-22 | 0001258394-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 106 | Section 02, Ian Clark 2026-08-04 | Form 4 | 2026-08-05 | 0001336504-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 107 | Section 02, Ian Clark 2026-08-04 | Form 4 | 2026-08-05 | 0001336504-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 108 | Section 02, Ian Clark 2026-08-04 | Form 4 | 2026-08-05 | 0001336504-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 109 | Section 02, Ian Clark 2026-08-04 | Form 4 | 2026-08-05 | 0001336504-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 110 | Section 02, Ian Clark 2026-08-04 | Form 4 | 2026-08-05 | 0001336504-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 111 | Section 02, Ian Clark 2026-08-04 | Form 4 | 2026-08-05 | 0001336504-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 112 | Section 02, Medina Manuel Hidalgo 2026-08-05 | Form 4 | 2026-08-06 | 0001865525-26-000024 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 113 | Section 02, Medina Manuel Hidalgo 2026-08-05 | Form 4 | 2026-08-06 | 0001865525-26-000024 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 114 | Section 02, Medina Manuel Hidalgo 2026-08-05 | Form 4 | 2026-08-06 | 0001865525-26-000024 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 115 | Section 02, Medina Manuel Hidalgo 2026-08-05 | Form 4 | 2026-08-06 | 0001865525-26-000024 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 116 | Section 02, Chris Freeman 2026-08-10 | Form 4 | 2026-08-11 | 0001871615-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 117 | Section 02, Chris Freeman 2026-08-10 | Form 4 | 2026-08-11 | 0001871615-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 118 | Section 02, Chris Freeman 2026-08-10 | Form 4 | 2026-08-11 | 0001871615-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 119 | Section 02, John Saia 2026-08-10 | Form 4 | 2026-08-12 | 0001737840-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 120 | Section 02, AmirAli Talasaz 2026-08-10 | Form 4 | 2026-08-12 | 0001753159-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 121 | Section 02, Chris Freeman 2026-08-10 | Form 4 | 2026-08-11 | 0001871615-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 122 | Section 02, Chris Freeman 2026-08-10 | Form 4 | 2026-08-11 | 0001871615-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 123 | Section 02, Chris Freeman 2026-08-10 | Form 4 | 2026-08-11 | 0001871615-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 124 | Section 02, AmirAli Talasaz 2026-08-10 | Form 4 | 2026-08-12 | 0001753159-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 125 | Section 02, Chris Freeman 2026-08-10 | Form 4 | 2026-08-11 | 0001871615-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 126 | Section 02, Chris Freeman 2026-08-10 | Form 4 | 2026-08-11 | 0001871615-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 127 | Section 02, Helmy Eltoukhy 2026-08-11 | Form 4 | 2026-08-12 | 0001752968-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 128 | Section 02, Helmy Eltoukhy 2026-08-11 | Form 4 | 2026-08-12 | 0001752968-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 129 | Section 02, Terilyn J. Monroe 2026-08-12 | Form 4 | 2026-08-13 | 0001652956-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 130 | Section 02, Terilyn J. Monroe 2026-08-12 | Form 4 | 2026-08-13 | 0001652956-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 131 | Section 02, Terilyn J. Monroe 2026-08-12 | Form 4 | 2026-08-13 | 0001652956-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 132 | Section 02, Terilyn J. Monroe 2026-08-12 | Form 4 | 2026-08-13 | 0001652956-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 133 | Section 02, Terilyn J. Monroe 2026-08-12 | Form 4 | 2026-08-13 | 0001652956-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 134 | Section 02, Terilyn J. Monroe 2026-08-12 | Form 4 | 2026-08-13 | 0001652956-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 135 | Section 02, Terilyn J. Monroe 2026-08-12 | Form 4 | 2026-08-13 | 0001652956-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 136 | Section 02, Terilyn J. Monroe 2026-08-12 | Form 4 | 2026-08-13 | 0001652956-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 137 | Section 02, Terilyn J. Monroe 2026-08-12 | Form 4 | 2026-08-13 | 0001652956-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 138 | Section 02, Musa Tariq 2026-08-15 | Form 4 | 2026-08-18 | 0001968281-26-000023 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 139 | Section 02, Musa Tariq 2026-08-15 | Form 4 | 2026-08-18 | 0001968281-26-000023 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 140 | Section 02, Musa Tariq 2026-08-17 | Form 4 | 2026-08-18 | 0001968281-26-000023 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 141 | Section 02, Medina Manuel Hidalgo 2026-08-17 | Form 4 | 2026-08-18 | 0001865525-26-000026 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 142 | Section 02, Medina Manuel Hidalgo 2026-08-17 | Form 4 | 2026-08-18 | 0001865525-26-000026 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 143 | Section 02, Roberto Mignone 2026-08-21 | Form 4 | 2026-08-24 | 0001258394-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 144 | Section 02, Roberto Mignone 2026-08-21 | Form 4 | 2026-08-24 | 0001258394-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 145 | Section 02, AmirAli Talasaz 2026-08-21 | Form 4 | 2026-08-24 | 0001753159-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 146 | Section 02, AmirAli Talasaz 2026-08-21 | Form 4 | 2026-08-24 | 0001753159-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 147 | Section 02, AmirAli Talasaz 2026-08-21 | Form 4 | 2026-08-24 | 0001753159-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 148 | Section 02, Helmy Eltoukhy 2026-08-26 | Form 4 | 2026-08-27 | 0001752968-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 149 | Section 02, Helmy Eltoukhy 2026-08-26 | Form 4 | 2026-08-27 | 0001752968-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 150 | Section 02, Helmy Eltoukhy 2026-08-26 | Form 4 | 2026-08-27 | 0001752968-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 151 | Section 02, Kumud Kalia 2026-09-11 | Form 4 | 2026-09-14 | 0001927831-26-000022 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 152 | Section 02, Alex M. Azar II 2026-09-12 | Form 4 | 2026-09-14 | 0001402256-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 153 | Section 02, Alex M. Azar II 2026-09-12 | Form 4 | 2026-09-14 | 0001402256-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 154 | Section 02, Musa Tariq 2026-09-15 | Form 4 | 2026-09-17 | 0001968281-26-000025 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 155 | Section 02, Darya Chudova 2026-09-15 | Form 4 | 2026-09-17 | 0001977179-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 156 | Section 02, Musa Tariq 2026-09-15 | Form 4 | 2026-09-17 | 0001968281-26-000025 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 157 | Section 02, Steve Krognes 2026-09-16 | Form 4 | 2026-09-17 | 0001666236-26-000024 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 158 | Section 02, Steve Krognes 2026-09-16 | Form 4 | 2026-09-17 | 0001666236-26-000024 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 159 | Section 02, Alex M. Azar II 2026-09-16 | Form 4 | 2026-09-17 | 0001402256-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 160 | Section 02, Musa Tariq 2026-09-16 | Form 4 | 2026-09-17 | 0001968281-26-000025 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 161 | Section 02, Steve Krognes 2026-09-16 | Form 4 | 2026-09-17 | 0001666236-26-000024 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 162 | Section 02, Steve Krognes 2026-09-16 | Form 4 | 2026-09-17 | 0001666236-26-000024 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 163 | Section 02, Medina Manuel Hidalgo 2026-09-17 | Form 4 | 2026-09-21 | 0001865525-26-000028 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 164 | Section 02, Medina Manuel Hidalgo 2026-09-17 | Form 4 | 2026-09-21 | 0001865525-26-000028 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 165 | Section 02, Roberto Mignone 2026-09-21 | Form 4 | 2026-09-22 | 0001258394-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 166 | Section 02, Roberto Mignone 2026-09-21 | Form 4 | 2026-09-22 | 0001258394-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 167 | Section 02, AmirAli Talasaz 2026-09-30 | Form 4 | 2026-10-02 | 0001753159-26-000022 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 168 | Section 02, AmirAli Talasaz 2026-09-30 | Form 4 | 2026-10-02 | 0001753159-26-000022 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 169 | Section 02, AmirAli Talasaz 2026-09-30 | Form 4 | 2026-10-02 | 0001753159-26-000022 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 170 | Section 02, Helmy Eltoukhy 2026-09-30 | Form 4 | 2026-10-02 | 0001752968-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 171 | Section 02, Helmy Eltoukhy 2026-09-30 | Form 4 | 2026-10-02 | 0001752968-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 172 | Section 02, Helmy Eltoukhy 2026-09-30 | Form 4 | 2026-10-02 | 0001752968-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 173 | Section 02, Darya Chudova 2026-10-01 | Form 4 | 2026-10-02 | 0001977179-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 174 | Section 02, Darya Chudova 2026-10-01 | Form 4 | 2026-10-02 | 0001977179-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 175 | Section 02, Darya Chudova 2026-10-01 | Form 4 | 2026-10-02 | 0001977179-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 176 | Section 02, Darya Chudova 2026-10-01 | Form 4 | 2026-10-02 | 0001977179-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 177 | Section 02, Darya Chudova 2026-10-01 | Form 4 | 2026-10-02 | 0001977179-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 178 | Section 02, Darya Chudova 2026-10-01 | Form 4 | 2026-10-02 | 0001977179-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 179 | Section 02, Darya Chudova 2026-10-01 | Form 4 | 2026-10-02 | 0001977179-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 180 | Section 02, Darya Chudova 2026-10-01 | Form 4 | 2026-10-02 | 0001977179-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 181 | Section 02, John Saia 2026-10-01 | Form 4 | 2026-10-02 | 0001737840-26-000022 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 182 | Section 02, John Saia 2026-10-01 | Form 4 | 2026-10-02 | 0001737840-26-000022 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 183 | Section 02, Darya Chudova 2026-10-01 | Form 4 | 2026-10-02 | 0001977179-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 184 | Section 02, AmirAli Talasaz 2026-10-01 | Form 4 | 2026-10-02 | 0001753159-26-000022 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 185 | Section 02, AmirAli Talasaz 2026-10-01 | Form 4 | 2026-10-02 | 0001753159-26-000022 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 186 | Section 02, AmirAli Talasaz 2026-10-01 | Form 4 | 2026-10-02 | 0001753159-26-000022 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 187 | Section 02, AmirAli Talasaz 2026-10-01 | Form 4 | 2026-10-02 | 0001753159-26-000022 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 188 | Section 02, AmirAli Talasaz 2026-10-01 | Form 4 | 2026-10-02 | 0001753159-26-000022 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 189 | Section 02, Helmy Eltoukhy 2026-10-01 | Form 4 | 2026-10-02 | 0001752968-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 190 | Section 02, Helmy Eltoukhy 2026-10-01 | Form 4 | 2026-10-02 | 0001752968-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 191 | Section 02, Helmy Eltoukhy 2026-10-01 | Form 4 | 2026-10-02 | 0001752968-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 192 | Section 02, Helmy Eltoukhy 2026-10-01 | Form 4 | 2026-10-02 | 0001752968-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 193 | Section 02, Helmy Eltoukhy 2026-10-01 | Form 4 | 2026-10-02 | 0001752968-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 194 | Section 02, Terilyn J. Monroe 2026-10-01 | Form 4 | 2026-10-02 | 0001652956-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 195 | Section 02, Terilyn J. Monroe 2026-10-01 | Form 4 | 2026-10-02 | 0001652956-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 196 | Section 02, Terilyn J. Monroe 2026-10-01 | Form 4 | 2026-10-02 | 0001652956-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 197 | Section 02, John Saia 2026-10-01 | Form 4 | 2026-10-02 | 0001737840-26-000022 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 198 | Section 02, John Saia 2026-10-01 | Form 4 | 2026-10-02 | 0001737840-26-000022 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 199 | Section 02, John Saia 2026-10-01 | Form 4 | 2026-10-02 | 0001737840-26-000022 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 200 | Section 02, John Saia 2026-10-01 | Form 4 | 2026-10-02 | 0001737840-26-000022 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 201 | Section 02, Terilyn J. Monroe 2026-10-01 | Form 4 | 2026-10-02 | 0001652956-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 202 | Section 02, Terilyn J. Monroe 2026-10-01 | Form 4 | 2026-10-02 | 0001652956-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 203 | Section 02, Kumud Kalia 2026-10-01 | Form 4 | 2026-10-02 | 0001927831-26-000024 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 204 | Section 02, Kumud Kalia 2026-10-01 | Form 4 | 2026-10-02 | 0001927831-26-000024 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 205 | Section 02, Kumud Kalia 2026-10-01 | Form 4 | 2026-10-02 | 0001927831-26-000024 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 206 | Section 02, Kumud Kalia 2026-10-01 | Form 4 | 2026-10-02 | 0001927831-26-000024 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 207 | Section 02, Kumud Kalia 2026-10-01 | Form 4 | 2026-10-02 | 0001927831-26-000024 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 208 | Section 02, Kumud Kalia 2026-10-01 | Form 4 | 2026-10-02 | 0001927831-26-000024 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 209 | Section 02, Kumud Kalia 2026-10-01 | Form 4 | 2026-10-02 | 0001927831-26-000024 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 210 | Section 02, Kumud Kalia 2026-10-01 | Form 4 | 2026-10-02 | 0001927831-26-000024 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 211 | Section 02, Kumud Kalia 2026-10-01 | Form 4 | 2026-10-02 | 0001927831-26-000024 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 212 | Section 02, Chris Freeman 2026-10-01 | Form 4 | 2026-10-02 | 0001871615-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 213 | Section 02, Chris Freeman 2026-10-01 | Form 4 | 2026-10-02 | 0001871615-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 214 | Section 02, Chris Freeman 2026-10-01 | Form 4 | 2026-10-02 | 0001871615-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 215 | Section 02, Chris Freeman 2026-10-01 | Form 4 | 2026-10-02 | 0001871615-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 216 | Section 02, Chris Freeman 2026-10-01 | Form 4 | 2026-10-02 | 0001871615-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 217 | Section 02, Chris Freeman 2026-10-01 | Form 4 | 2026-10-02 | 0001871615-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 218 | Section 02, Chris Freeman 2026-10-01 | Form 4 | 2026-10-02 | 0001871615-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 219 | Section 02, Chris Freeman 2026-10-01 | Form 4 | 2026-10-02 | 0001871615-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 220 | Section 02, Chris Freeman 2026-10-01 | Form 4 | 2026-10-02 | 0001871615-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 221 | Section 02, John Saia 2026-10-01 | Form 4 | 2026-10-02 | 0001737840-26-000022 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 222 | Section 02, John Saia 2026-10-01 | Form 4 | 2026-10-02 | 0001737840-26-000022 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 223 | Section 02, John Saia 2026-10-01 | Form 4 | 2026-10-02 | 0001737840-26-000022 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 224 | Section 02, Michael Bell 2026-10-01 | Form 4 | 2026-10-02 | 0001702824-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 225 | Section 02, Michael Bell 2026-10-01 | Form 4 | 2026-10-02 | 0001702824-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 226 | Section 02, Michael Bell 2026-10-01 | Form 4 | 2026-10-02 | 0001702824-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 227 | Section 02, Michael Bell 2026-10-01 | Form 4 | 2026-10-02 | 0001702824-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 228 | Section 02, Michael Bell 2026-10-01 | Form 4 | 2026-10-02 | 0001702824-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 229 | Section 02, Michael Bell 2026-10-01 | Form 4 | 2026-10-02 | 0001702824-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 230 | Section 02, Michael Bell 2026-10-01 | Form 4 | 2026-10-02 | 0001702824-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 231 | Section 02, Alex M. Azar II 2026-10-12 | Form 4 | 2026-10-13 | 0001402256-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 232 | Section 02, Alex M. Azar II 2026-10-12 | Form 4 | 2026-10-13 | 0001402256-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 233 | Section 02, Alex M. Azar II 2026-10-14 | Form 4 | 2026-10-15 | 0001402256-26-000010 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 234 | Section 02, Musa Tariq 2026-10-15 | Form 4 | 2026-10-19 | 0001968281-26-000027 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 235 | Section 02, Musa Tariq 2026-10-15 | Form 4 | 2026-10-19 | 0001968281-26-000027 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 236 | Section 02, Musa Tariq 2026-10-16 | Form 4 | 2026-10-19 | 0001968281-26-000027 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 237 | Section 02, Medina Manuel Hidalgo 2026-10-17 | Form 4 | 2026-10-19 | 0001865525-26-000030 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 238 | Section 02, Medina Manuel Hidalgo 2026-10-17 | Form 4 | 2026-10-19 | 0001865525-26-000030 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 239 | Section 06, 2026 vote | Form 8-K | 2026-06-18 | 0001193125-26-275864 | Item 5.07 · say-on-pay result. As reported: 90.84% (votes for as printed: 98,236,639). Filing ↗ |
| 240 | Section 06, 2025 vote | Form 8-K | 2025-06-20 | 0001193125-25-143681 | Item 5.07 · say-on-pay result. As reported: 92.85% (votes for as printed: 91,189,702). Filing ↗ |
| 241 | Section 06, 2024 vote | Form 8-K | 2024-06-14 | 0001193125-24-161223 | Item 5.07 · say-on-pay result. As reported: 93.57% (votes for as printed: 84,585,946). Filing ↗ |
| 242 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 243 | Section 03b vehicle mix (computed) | Computed | — | — | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 244 | Section 09b board cost (computed) | Computed | — | — | Cash 0 + equity 2,107,851 + all other 0 = 2,107,851, summed across the director compensation table rows.machine: formula: Σ = 2,107,851 |
| 245 | Tempus AI, Inc., Section 10b CEO total | DEF 14A | 2026-04-07 | 0001193125-26-145528 | CEO total compensation as printed in Tempus AI, Inc.'s own proxy. As printed: 41,495,833. Filing ↗machine: r2 · c27 · span 345457–345467 |
| 246 | Exelixis, Inc., Section 10b CEO total | DEF 14A | 2026-04-15 | 0000939767-26-000046 | CEO total compensation as printed in Exelixis, Inc.'s own proxy. As printed: 33,239,183. Filing ↗machine: r2 · c10 · span 2655516–2655526 |
| 247 | BioMarin Pharmaceuticals Inc., Section 10b CEO total | DEF 14A | 2026-04-21 | 0001628280-26-026290 | CEO total compensation as printed in BioMarin Pharmaceuticals Inc.'s own proxy. As printed: 21,927,563. Filing ↗machine: span 1384905–1384915 |
| 248 | Masimo Corporation, Section 10b CEO total | 10-K | 2026-05-01 | 0001104659-26-054180 | CEO total compensation as printed in Masimo Corporation's own proxy. As printed: 19,797,140. Filing ↗machine: r4 · c22 · span 477159–477169 |
| 249 | Insulet Corporation, Section 10b CEO total | DEF 14A | 2026-04-06 | 0001140361-26-013333 | CEO total compensation as printed in Insulet Corporation's own proxy. As printed: 18,858,968. Filing ↗machine: t218 · r3 · c25 · span 1028076–1028087 |
| 250 | United Therapeutics Corp, Section 10b CEO total | DEF 14A | 2026-04-29 | 0001082554-26-000009 | CEO total compensation as printed in United Therapeutics Corp's own proxy. As printed: 18,038,972. Filing ↗machine: span 1993726–1993736 |
| 251 | Exact Sciences Corporation, Section 10b CEO total | DEF 14A | 2025-04-29 | 0001124140-25-000034 | CEO total compensation as printed in Exact Sciences Corporation's own proxy. As printed: 15,539,378. Filing ↗machine: span 1077855–1077865 |
| 252 | Natera, Inc., Section 10b CEO total | DEF 14A | 2026-04-23 | 0001104659-26-047770 | CEO total compensation as printed in Natera, Inc.'s own proxy. As printed: 14,957,319. Filing ↗machine: t190 · r5 · c14 · span 1269868–1269878 |
| 253 | Alnylam Pharmaceuticals, Inc., Section 10b CEO total | DEF 14A | 2026-04-06 | 0001628280-26-023923 | CEO total compensation as printed in Alnylam Pharmaceuticals, Inc.'s own proxy. As printed: 14,867,600. Filing ↗machine: span 1294691–1294701 |
| 254 | IDEXX Laboratories, Inc., Section 10b CEO total | DEF 14A | 2026-03-27 | 0000874716-26-000064 | CEO total compensation as printed in IDEXX Laboratories, Inc.'s own proxy. As printed: 14,580,122. Filing ↗machine: span 1576008–1576018 |
| 255 | Neurocrine Biosciences, Inc., Section 10b CEO total | DEF 14A | 2026-04-15 | 0000914475-26-000015 | CEO total compensation as printed in Neurocrine Biosciences, Inc.'s own proxy. As printed: 13,448,935. Filing ↗machine: t50 · r4 · c7 · span 847947–847957 |
| 256 | Illumina, Inc., Section 10b CEO total | DEF 14A | 2026-04-09 | 0001193125-26-149669 | CEO total compensation as printed in Illumina, Inc.'s own proxy. As printed: 11,018,895. Filing ↗machine: r4 · c14 · span 728526–728536 |
| 257 | iRhythm Technologies, Inc., Section 10b CEO total | DEF 14A | 2026-04-17 | 0001388658-26-000030 | CEO total compensation as printed in iRhythm Technologies, Inc.'s own proxy. As printed: 11,003,163. Filing ↗machine: r2 · c21 · span 1123498–1123508 |
| 258 | NeoGenomics, Inc., Section 10b CEO total | DEF 14A | 2026-04-06 | 0001077183-26-000014 | CEO total compensation as printed in NeoGenomics, Inc.'s own proxy. As printed: 9,127,092. Filing ↗machine: r2 · c45 · span 869460–869469 |
| 259 | Guardant Health (subject), Section 10b CEO total | DEF 14A | 2026-04-28 | 0001193125-26-187403 | CEO total compensation as printed in Guardant Health's own proxy. As printed: 8,661,227. Filing ↗machine: r7 · c31 · span 773149–773158 |
| 260 | ACADIA Pharmaceuticals Inc., Section 10b CEO total | DEF 14A | 2026-04-24 | 0001193125-26-174163 | CEO total compensation as printed in ACADIA Pharmaceuticals Inc.'s own proxy. As printed: 8,256,518. Filing ↗ |
| 261 | Dexcom, Inc., Section 10b CEO total | DEF 14A | 2026-04-15 | 0001093557-26-000061 | CEO total compensation as printed in Dexcom, Inc.'s own proxy. As printed: 7,985,960. Filing ↗machine: span 940364–940373 |
| 262 | Section 10a, Insulet Corporation reciprocity | DEF 14A | — | 0001140361-26-013333 | Insulet Corporation's most recent proxy was read; its disclosed peer group does not include Guardant Health. Filing ↗ |
| 263 | Section 10a, Alnylam Pharmaceuticals, Inc. reciprocity | DEF 14A | — | 0001628280-26-023923 | Alnylam Pharmaceuticals, Inc.'s most recent proxy was read; its disclosed peer group does not include Guardant Health. Filing ↗ |
| 264 | Section 10a, BioMarin Pharmaceuticals Inc. reciprocity | DEF 14A | — | 0001628280-26-026290 | BioMarin Pharmaceuticals Inc.'s most recent proxy was read; its disclosed peer group does not include Guardant Health. Filing ↗ |
| 265 | Section 10a, Masimo Corporation reciprocity | DEF 14A | — | 0001104659-26-054180 | Masimo Corporation's most recent proxy was read; its disclosed peer group does not include Guardant Health. Filing ↗ |
| 266 | Section 10a, Dexcom, Inc. reciprocity | DEF 14A | — | 0001093557-26-000061 | Dexcom, Inc.'s most recent proxy was read; its disclosed peer group does not include Guardant Health. Filing ↗ |
| 267 | Section 10a, NeoGenomics, Inc. reciprocity | DEF 14A | — | 0001077183-26-000014 | NeoGenomics, Inc. names Guardant Health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 268 | Section 10a, Neurocrine Biosciences, Inc. reciprocity | DEF 14A | — | 0000914475-26-000015 | Neurocrine Biosciences, Inc.'s most recent proxy was read; its disclosed peer group does not include Guardant Health. Filing ↗ |
| 269 | Section 10a, Tempus AI, Inc. reciprocity | DEF 14A | — | 0001193125-26-145528 | Tempus AI, Inc. names Guardant Health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 270 | Section 10a, IDEXX Laboratories, Inc. reciprocity | DEF 14A | — | 0000874716-26-000064 | IDEXX Laboratories, Inc.'s most recent proxy was read; its disclosed peer group does not include Guardant Health. Filing ↗ |
| 271 | Section 10a, United Therapeutics Corp reciprocity | DEF 14A | — | 0001082554-26-000009 | United Therapeutics Corp's most recent proxy was read; its disclosed peer group does not include Guardant Health. Filing ↗ |
| 272 | Section 10a, iRhythm Technologies, Inc. reciprocity | DEF 14A | — | 0001388658-26-000030 | iRhythm Technologies, Inc.'s most recent proxy was read; its disclosed peer group does not include Guardant Health. Filing ↗ |
| 273 | Section 10a, Exact Sciences Corporation reciprocity | DEF 14A | — | 0001124140-25-000034 | Exact Sciences Corporation names Guardant Health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 274 | Section 10a, Natera, Inc. reciprocity | DEF 14A | — | 0001104659-26-047770 | Natera, Inc. names Guardant Health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 275 | Section 10a, ACADIA Pharmaceuticals Inc. reciprocity | DEF 14A | — | 0001193125-26-174163 | ACADIA Pharmaceuticals Inc.'s most recent proxy was read; its disclosed peer group does not include Guardant Health. Filing ↗ |
| 276 | Section 10a, Exelixis, Inc. reciprocity | DEF 14A | — | 0000939767-26-000046 | Exelixis, Inc.'s most recent proxy was read; its disclosed peer group does not include Guardant Health. Filing ↗ |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.